Biogen to Present at the Goldman Sachs Alzheimer’s Symposium

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Goldman Sachs Alzheimer’s Symposium. The webcast will be live on Monday, April 11, 2016 at 12:20p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160328005577/en/

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Source: Biogen Inc.

You May Also Be Interested In

• Biogen (BIIB) PT Raised to $260 at RBC Capital, 'Deep Dive Suggests Upcoming Liti SLE Data Could Start I&I Buildout On Right Path'
• Jukebox Launches Free 4x HD Image Upscaling Inside Its Background Remover, No Signup Required
• Missed Bitcoin and XRP’s Early Gains? Apeing Could Be the Next Big Crypto Before the Crowd Arrives – Presale Coming Soon